Amy Lewis

712 total citations
18 papers, 513 citations indexed

About

Amy Lewis is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Amy Lewis has authored 18 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in Amy Lewis's work include Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Nutrition and Health in Aging (6 papers) and Extracellular vesicles in disease (2 papers). Amy Lewis is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Nutrition and Health in Aging (6 papers) and Extracellular vesicles in disease (2 papers). Amy Lewis collaborates with scholars based in United Kingdom, United States and Sweden. Amy Lewis's co-authors include Michael I. Polkey, Paul R. Kemp, Nicholas S Hopkinson, Anna Donaldson, William D‐C Man, Samantha A. Natanek, John Moxham, Joanna Riddoch‐Contreras, Susannah Bloch and Benjamin Garfield and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Amy Lewis

17 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Lewis United Kingdom 8 260 206 170 160 86 18 513
Anna Donaldson United Kingdom 7 234 0.9× 185 0.9× 161 0.9× 132 0.8× 82 1.0× 13 450
Jiangling Dong China 8 296 1.1× 267 1.3× 37 0.2× 17 0.1× 39 0.5× 18 519
Xinying Yang China 8 276 1.1× 26 0.1× 82 0.5× 34 0.2× 15 0.2× 19 458
Radwan Safa United States 9 175 0.7× 54 0.3× 34 0.2× 18 0.1× 29 0.3× 14 421
Wuyuan Tao China 9 96 0.4× 158 0.8× 49 0.3× 72 0.5× 7 0.1× 12 352
Andrew J. Bryant United States 13 140 0.5× 53 0.3× 42 0.2× 255 1.6× 8 0.1× 34 483
Sara Peixoto da Silva Portugal 6 142 0.5× 177 0.9× 89 0.5× 26 0.2× 34 0.4× 10 357
Feifei Chen China 10 124 0.5× 24 0.1× 59 0.3× 48 0.3× 71 0.8× 29 347
Weisheng Bao Canada 9 155 0.6× 94 0.5× 58 0.3× 149 0.9× 2 0.0× 11 432
Haichao Wang China 8 174 0.7× 64 0.3× 43 0.3× 48 0.3× 6 0.1× 18 340

Countries citing papers authored by Amy Lewis

Since Specialization
Citations

This map shows the geographic impact of Amy Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Lewis more than expected).

Fields of papers citing papers by Amy Lewis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Lewis. The network helps show where Amy Lewis may publish in the future.

Co-authorship network of co-authors of Amy Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Lewis. A scholar is included among the top collaborators of Amy Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Lewis. Amy Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Paúl, Richard, Amy Lewis, Benjamin Garfield, et al.. (2017). MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit–acquired Weakness. American Journal of Respiratory and Critical Care Medicine. 196(11). 1422–1433. 62 indexed citations
2.
Patel, Mehul S., Anna Donaldson, Amy Lewis, et al.. (2016). Klotho and smoking – An interplay influencing the skeletal muscle function deficits that occur in COPD. Respiratory Medicine. 113. 50–56. 23 indexed citations
3.
Mohan, Divya, Amy Lewis, Mehul S. Patel, et al.. (2016). Using laser capture microdissection to study fiber specific signaling in locomotor muscle in COPD: A pilot study. Muscle & Nerve. 55(6). 902–912. 2 indexed citations
4.
Lewis, Amy, Anna Donaldson, Samantha A. Natanek, et al.. (2016). Increased expression of H19/miR‐675 is associated with a low fat‐free mass index in patients with COPD. Journal of Cachexia Sarcopenia and Muscle. 7(3). 330–344. 45 indexed citations
5.
Bloch, Susannah, Anna Donaldson, Amy Lewis, et al.. (2015). MiR-181a: a potential biomarker of acute muscle wasting following elective high-risk cardiothoracic surgery. Critical Care. 19(1). 147–147. 19 indexed citations
6.
Patel, Mehul S., Susannah Bloch, Amy Lewis, et al.. (2015). Growth differentiation factor‐15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. Journal of Cachexia Sarcopenia and Muscle. 7(4). 436–448. 89 indexed citations
7.
Shrikrishna, Dinesh, Rebecca Tanner, Amy Lewis, et al.. (2014). A Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibition for Skeletal Muscle Dysfunction in COPD. CHEST Journal. 146(4). 932–940. 25 indexed citations
8.
Patel, Mehul S., Amy Lewis, Samantha A. Natanek, et al.. (2013). Klotho expression is reduced in COPD. European Respiratory Journal. 42(Suppl 57). P3708–P3708. 1 indexed citations
9.
Donaldson, Anna, Samantha A. Natanek, Amy Lewis, et al.. (2013). Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Thorax. 68(12). 1140–1149. 106 indexed citations
10.
Mohan, Divya, et al.. (2013). S53 Studying fibre specific gene expression in COPD using laser capture micro-dissection in human skeletal muscle. Thorax. 68(Suppl 3). A29.2–A30. 2 indexed citations
11.
Shrikrishna, Dinesh, Jae-Yeon Lee, Amy Lewis, et al.. (2012). S48 The Effect of Angiotensin-Converting Enzyme Inhibition on Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: A Randomised Controlled Trial. Thorax. 67(Suppl 2). A25.1–A25. 1 indexed citations
12.
Donaldson, Anna, Amy Lewis, Samantha A. Natanek, et al.. (2011). Investigating circulating microRNAs as potential biomarkers of quadriceps weakness in COPD. European Respiratory Journal. 38(Suppl 55). 206–206. 2 indexed citations
13.
Lewis, Amy, Joanna Riddoch‐Contreras, Samantha A. Natanek, et al.. (2011). Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax. 67(1). 26–34. 130 indexed citations
14.
Lewis, Amy, et al.. (2011). S49 Increased skeletal muscle-specific microRNA-1 in the blood of COPD patients. Thorax. 66(Suppl 4). A25–A25. 1 indexed citations
15.
Lewis, Amy, Joanna Riddoch‐Contreras, Samantha A. Natanek, et al.. (2010). Alterations In MRTF And FHL1 Activity Contribute To Fibre Type Shift In The Quadriceps Of Patients With COPD. A6611–A6611. 1 indexed citations
16.
Lewis, Amy, et al.. (1984). Pseudoinfarction without underlying cardiopulmonary pathology.. PubMed. 18(5). 767–8, 770. 1 indexed citations
17.
Carlisle, Raymond & Amy Lewis. (1977). Survival curves applied to acute myocardial infarction. American Heart Journal. 94(6). 807–809. 1 indexed citations
18.
Carlisle, Raymond & Amy Lewis. (1976). EXPONENTIAL CURVE OF TEMPORARY SURVIVAL AFTER MYOCARDIAL INFARCTION. The Lancet. 307(7964). 853–853. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026